Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI) has introduced its inaugural line of THCV products under the SHRED and Trailblazer brands.
The company has invested strategically in Phylos Bioscience, a leading US-based cannabis genetics company to secure a competitive edge in the cannabis sector.
Organigram reports that it cultivates and internally extracts THCV at its state-of-the-art Moncton facility, establishing itself as the sole licensed Canadian producer to undertake this process.
Megan McCrae, senior VP of marketing and communications at Organigram, emphasized the company's commitment to exceeding consumer expectations and reshaping the cannabis experience by leveraging the potential of THCV through strategic investments.
“In this era of heightened awareness, we recognize that consumers expect more from cannabis producers, and our commitment as an industry-leading Licensed Producer is to exceed those expectations. By harnessing the power of THCV through our strategic investment, we are reshaping the cannabis experience for consumers,” said McCrae.
The company reported THCV is a cannabinoid recognized for its appetite-suppressing properties and is gaining attention for its reported non-psychoactive nature and its potential to counteract certain aspects of THC.
The Benzinga Cannabis Capital Conference, the place where deals get done, is returning to Chicago this Sept. 27-28 for its 17th edition. Get your tickets today before prices increase and secure a spot at the epicenter of cannabis investment and branding.
Photo by: Sergei Tokmakov, Esq. https://Terms.Law via Pixabay.